Episode 62

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

Featuring perspectives from Dr Adam M Brufsky and Dr Kevin Kalinsky, including the following topics:

  • Introduction (0:00)
  • Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Therapy for Triple-Negative Breast Cancer (TNBC) — Dr Brufsky (5:08)
  • Established Treatment Paradigm for Localized and Metastatic TNBC — Dr Kalinsky (35:20)

CME information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Breast Cancer Update
Breast Cancer Update
This series bridges the gap between research and patient care by providing on-going access to the perspectives and opinions of national and international breast cancer research leaders.

Listen for free